Van Naarden Jacob

CIK 00016612542 companiesINDIANAPOLIS, IN

SEC Profile

Transactions

Companies

Filings

CIK

0001661254

Recent Transactions

50 trades

Purchase
ELI LILLY & Co$LLY
Common Stock
2025-08-13$647.36/sh+1,000→ 20,561.985 total
Award
ELI LILLY & Co$LLY
Common Stock
2025-02-10$868.88/sh+6,103.824→ 19,561.985 total
Award
ELI LILLY & Co$LLY
Restricted Stock Unit
2025-02-10+4,108→ 4,108 total
Exercise/Conversion
ELI LILLY & Co$LLY
Common Stock
2025-02-01+3,023→ 14,868 total
Tax Payment
ELI LILLY & Co$LLY
Common Stock
2025-02-01$811.08/sh−1,409.839→ 13,458.161 total
Exercise/Conversion
ELI LILLY & Co$LLY
Restricted Stock Unit
2025-02-01−3,023→ 0 total
Gift
ELI LILLY & Co$LLY
Common Stock
2024-10-31−4,302→ 11,845 total
Award
ELI LILLY & Co$LLY
Common Stock
2024-02-12$737.26/sh+2,369→ 16,147 total
Award
ELI LILLY & Co$LLY
Restricted Stock Unit
2024-02-12+3,023→ 3,023 total
Exercise/Conversion
ELI LILLY & Co$LLY
Common Stock
2024-02-01+3,618→ 15,463 total
Exercise/Conversion
ELI LILLY & Co$LLY
Restricted Stock Unit
2024-02-01−3,618→ 0 total
Tax Payment
ELI LILLY & Co$LLY
Common Stock
2024-02-01$645.61/sh−1,685→ 13,778 total
Tax Payment
ELI LILLY & Co$LLY
Common Stock
2023-02-16$335.01/sh−1,314→ 11,845 total
Exercise/Conversion
ELI LILLY & Co$LLY
Restricted Stock Unit
2023-02-16−2,785→ 0 total
Exercise/Conversion
ELI LILLY & Co$LLY
Common Stock
2023-02-16+2,785→ 13,159 total
Award
ELI LILLY & Co$LLY
Common Stock
2023-02-10$345.12/sh+2,407→ 10,374 total
Exercise/Conversion
ELI LILLY & Co$LLY
Common Stock
2022-02-16+5,461→ 10,153 total
Exercise/Conversion
ELI LILLY & Co$LLY
Restricted Stock Unit
2022-02-16−5,461→ 0 total
Tax Payment
ELI LILLY & Co$LLY
Common Stock
2022-02-16$243.84/sh−2,186→ 7,967 total
Award
ELI LILLY & Co$LLY
Restricted Stock Unit
2021-12-28+3,618→ 3,618 total
Disposition to Issuer
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2019-02-15$235.00/sh−35,000→ 0 total
Disposition to Issuer
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2019-02-15$235.00/sh−74,000→ 0 total
Disposition to Issuer
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2019-02-15$235.00/sh−35,026→ 0 total
Disposition to Issuer
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2019-02-15$235.00/sh−43,000→ 0 total
Disposition to Issuer
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2019-02-15$235.00/sh−57,000→ 0 total
Disposition to Issuer
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2019-02-15$235.00/sh−200,000→ 0 total
Disposition to Issuer
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2019-02-15$235.00/sh−78,943→ 0 total
Disposition to Issuer
Loxo Oncology, Inc.
Common Stock
2019-02-15$235.00/sh−19,000→ 0 total
Award
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2019-01-02+57,000→ 57,000 total
Exercise/Conversion
Loxo Oncology, Inc.
Common Stock
2018-12-11$13.67/sh+4,500→ 18,200 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-12-11$134.74/sh−400→ 17,800 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-12-11$135.92/sh−800→ 17,000 total
Exercise/Conversion
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2018-12-11−7,000→ 33,326 total
Exercise/Conversion
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2018-12-11−4,500→ 78,943 total
Exercise/Conversion
Loxo Oncology, Inc.
Common Stock
2018-12-11$3.65/sh+7,000→ 20,700 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-12-11$137.73/sh−500→ 14,741 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-12-11$139.23/sh−500→ 14,241 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-12-11$137.09/sh−1,759→ 15,241 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-12-11$140.16/sh−541→ 13,700 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-12-10$133.17/sh−900→ 15,900 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-12-10$132.23/sh−1,000→ 16,800 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-12-10$130.59/sh−400→ 17,800 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-12-10$136.48/sh−200→ 13,800 total
Exercise/Conversion
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2018-12-10−4,500→ 83,443 total
Exercise/Conversion
Loxo Oncology, Inc.
Common Stock
2018-12-10$13.67/sh+4,500→ 18,200 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-12-10$134.65/sh−1,400→ 14,500 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-12-10$135.14/sh−500→ 14,000 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-12-10$137.39/sh−100→ 13,700 total
Exercise/Conversion
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2018-11-27−2,057→ 87,943 total
Exercise/Conversion
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2018-11-27−2,443→ 40,326 total

Companies

Recent Filings

Address

LILLY CORPORATE CENTER

INDIANAPOLIS, IN, 46285

View on SEC.gov